Pathogen: SARS-CoV-2

Patel

United Kingdom
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Paediatric
  • Primary care
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

Drysdale

Belgium
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

De Vito

Italy
|
2022-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Basoulis

Greece
|
2022-2023
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Nirmatrelvir/Ritonavir

COCOPREV

France
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Patel

United Kingdom
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • Paediatric
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

Ismail

Greece Denmark Germany
|
2020-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Statins

Rinaldi

Italy
|
2022-2022
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Perrotta

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Hospital wide
  • Emergency department
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • Bamlanivimab/ Etesevimab

Gentile

Italy
|
2023-2023
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab

Drysdale

United Kingdom
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • Primary care
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

Rotundo

Italy
|
2022-2023
  • Adults
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab